Cumberland Pharmaceuticals (CPIX) EBIT: 2009-2025
Historic EBIT for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$2.0 million.
- Cumberland Pharmaceuticals' EBIT fell 15.98% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.70%. This contributed to the annual value of -$6.4 million for FY2024, which is 32.68% up from last year.
- According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' EBIT is -$2.0 million, which was down 162.92% from -$747,478 recorded in Q2 2025.
- Cumberland Pharmaceuticals' EBIT's 5-year high stood at $1.3 million during Q1 2025, with a 5-year trough of -$6.2 million in Q4 2023.
- In the last 3 years, Cumberland Pharmaceuticals' EBIT had a median value of -$1.7 million in 2024 and averaged -$1.6 million.
- Its EBIT has fluctuated over the past 5 years, first slumped by 4,591.40% in 2024, then soared by 169.12% in 2025.
- Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' EBIT stood at -$4.4 million in 2021, then spiked by 47.68% to -$2.3 million in 2022, then tumbled by 171.28% to -$6.2 million in 2023, then soared by 70.19% to -$1.8 million in 2024, then declined by 15.98% to -$2.0 million in 2025.
- Its EBIT was -$2.0 million in Q3 2025, compared to -$747,478 in Q2 2025 and $1.3 million in Q1 2025.